Horizon, Ventana sign co-development agreement, 11/16

November 2016—Horizon Discovery has entered into a co-development and commercialization agreement with Ventana Medical Systems, a member of the Roche group. The agreement covers the development, manufacture, and commercialization of cell-line derivative materials for use as immunohistochemistry reference standards in cancer tissue diagnostics to support the development and validation of IHC assays.

Under the terms of the agreement, Ventana has the option to commission projects from Horizon, whereupon Horizon will develop the applicable cell lines and the associated derivative reference standard materials. Horizon will retain primary responsibility for commercializing the reference standards and will serve as the primary distribution channel to end customers in the tissue diagnostics market. Ventana will hold the option to co-distribute any developed reference standards.

Horizon Discovery, +44 (0) 1223 655 580

Ventana Medical Systems, 520-887-2155